alfuzosin has been researched along with Postoperative Complications in 6 studies
alfuzosin: structure given in first source
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used a double blind, placebo-controlled trial in which 249 patients with postoperative urinary retention were randomly assigned to receive carbachol/diazepam (n = 72), alfusozine (n = 82), or placebo (n = 95)." | 9.08 | Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine. ( Boutkan, H; Breslau, PJ; Burger, DH; Kappetein, AP, 1997) |
| "To compare the incidence of intraoperative floppy-iris syndrome (IFIS) in men exposed to tamsulosin and men exposed to alfuzosin and evaluate the effect of IFIS on the complication rate of cataract surgery." | 7.74 | Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. ( Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S, 2007) |
| "To assess the symptomatic outcome following transurethral prostatectomy (TURP), alpha-blockade and placebo treatment in uncomplicated benign prostatic hyperplasia (BPH), 260 patients were evaluated with the recently formulated Danish Prostatic Symptom Score (DAN-PSS-1) system: 205 were randomized to either the selective alpha-blocker alfuzosin or placebo and 55 underwent TURP." | 5.08 | Symptomatic outcome of transurethral prostatectomy, alpha-blockade and placebo in the treatment of benign prostatic hyperplasia. Evaluation of treatment with the Danish Prostatic Symptom Score (DAN-PSS-1) system. The ALFECH Study Group. ( Flyger, H; Hansen, BJ; Mensink, HJ; Meyhoff, HH; Mortensen, S, 1996) |
| "We used a double blind, placebo-controlled trial in which 249 patients with postoperative urinary retention were randomly assigned to receive carbachol/diazepam (n = 72), alfusozine (n = 82), or placebo (n = 95)." | 5.08 | Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine. ( Boutkan, H; Breslau, PJ; Burger, DH; Kappetein, AP, 1997) |
| "To compare the incidence of intraoperative floppy-iris syndrome (IFIS) in men exposed to tamsulosin and men exposed to alfuzosin and evaluate the effect of IFIS on the complication rate of cataract surgery." | 3.74 | Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. ( Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S, 2007) |
| "To determine the effectiveness of alfuzosin on symptom reduction, patients' perceived health-related quality of life (HRQL) improvement, adverse outcomes, treatment failure, and progression to acute urinary retention and prostate surgery in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH) in a 1-year prospective, open-labeled study." | 3.70 | One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice. ( Comet, D; Grange, JC; Lukacs, B, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SC | 1 |
| Jung, SW | 1 |
| Lee, JW | 1 |
| Rim, JS | 1 |
| Deliveliotis, C | 1 |
| Chrisofos, M | 1 |
| Gougousis, E | 1 |
| Papatsoris, A | 1 |
| Dellis, A | 1 |
| Varkarakis, IM | 1 |
| Blouin, MC | 1 |
| Blouin, J | 1 |
| Perreault, S | 1 |
| Lapointe, A | 1 |
| Dragomir, A | 1 |
| Hansen, BJ | 1 |
| Flyger, H | 1 |
| Mortensen, S | 1 |
| Mensink, HJ | 1 |
| Meyhoff, HH | 1 |
| Burger, DH | 1 |
| Kappetein, AP | 1 |
| Boutkan, H | 1 |
| Breslau, PJ | 1 |
| Lukacs, B | 1 |
| Grange, JC | 1 |
| Comet, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management[NCT01381120] | Phase 4 | 84 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Measured through the use of the ureteral stent symptom questionnaire. Patients reported symptoms on a scale of 1 to 5 (1 being the absence of symptoms and 5 being very debilitating symptoms). The questionnaire was administered a couple days post-op and once again several weeks later. The mean difference (baseline minus 3 months) on this continuous scale was used for this outcome measure. (NCT01381120)
Timeframe: Baseline and three months.
| Intervention | units on a scale (Mean) |
|---|---|
| VESIcare + Narcotic Painkiller | 1.90 |
| Narcotic Painkiller | 1.13 |
Measured through the use of the ureteral stent symptom questionnaire. Patients reported pain on a scale of 0 to 10 (0 being the absence of pain and 10 being the most excruciating pain of their life). The questionnaire was administered a couple days post-op and once again several weeks later. The mean difference (baseline minus 3 months) on this continuous scale was used for this outcome measure. (NCT01381120)
Timeframe: Baseline and 3 months.
| Intervention | units on a scale (Mean) |
|---|---|
| VESIcare + Narcotic Painkiller | 4.61 |
| Narcotic Painkiller | 3.11 |
4 trials available for alfuzosin and Postoperative Complications
| Article | Year |
|---|---|
The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cres | 2009 |
Is there a role for alpha1-blockers in treating double-J stent-related symptoms?
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Female; Humans; Hydronephrosis; Male; Middle Aged; Postop | 2006 |
Symptomatic outcome of transurethral prostatectomy, alpha-blockade and placebo in the treatment of benign prostatic hyperplasia. Evaluation of treatment with the Danish Prostatic Symptom Score (DAN-PSS-1) system. The ALFECH Study Group.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Follow-Up Studies; Humans; Male; Middle Aged; | 1996 |
Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine.
Topics: Adrenergic alpha-Antagonists; Aged; Carbachol; Diazepam; Double-Blind Method; Drug Therapy, Combinat | 1997 |
2 other studies available for alfuzosin and Postoperative Complications
| Article | Year |
|---|---|
Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Incidence; Intr | 2007 |
One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Family Practice; Follow-Up Studies; Humans; M | 2000 |